Summary c-LEcta GmbH (c-LEcta) is a biotechnology company that develops sustainable industrial processes and microbial production strains. The company’s product line includes acrylaway hight, denarase, calb immo plus, nucleanase, and customized enzyme C-lections. It offers technologies that include biodiversity, enzyme engineering, strain engineering and bioprocess development. c-LEcta possesses ready-to-screen metagenomic expression libraries from different habitats, including environments such as sheep rumen, chemical industry-contaminated soil or high-temperature decomposition material. The company also comprises still growing collection of several thousand pre-qualified, dereplicated cultivable microorganisms from different habitats. It mainly uses microorganisms as miniaturized living factories to produce products. The company’s enzyme engineering platform allows the rapid development of enzymes with undescribed, artificial activities. c-LEcta is headquartered in Leipzig, Germany. c-LEcta GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.... Research Beam Model: Research Beam Product ID: 1043992 250 USD New
c-LEcta GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

c-LEcta GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : November   2016
  • Pages : 15
  • Publisher : GlobalData
 
 
 
Summary

c-LEcta GmbH (c-LEcta) is a biotechnology company that develops sustainable industrial processes and microbial production strains. The company’s product line includes acrylaway hight, denarase, calb immo plus, nucleanase, and customized enzyme C-lections. It offers technologies that include biodiversity, enzyme engineering, strain engineering and bioprocess development. c-LEcta possesses ready-to-screen metagenomic expression libraries from different habitats, including environments such as sheep rumen, chemical industry-contaminated soil or high-temperature decomposition material. The company also comprises still growing collection of several thousand pre-qualified, dereplicated cultivable microorganisms from different habitats. It mainly uses microorganisms as miniaturized living factories to produce products. The company’s enzyme engineering platform allows the rapid development of enzymes with undescribed, artificial activities. c-LEcta is headquartered in Leipzig, Germany.

c-LEcta GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
c-LEcta GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
c-LEcta GmbH, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
c-LEcta GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
c-LEcta GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 8
c-LEcta GmbH, Pharmaceuticals & Healthcare, Deal Details 9
Partnerships 9
c-LEcta Enters into Co-Marketing Agreement with Purolite for CalB immo Plus 9
Sartorius Stedim Biotech Enters Into Co-Marketing Agreement With c-LEcta 10
Licensing Agreements 11
DSM Pharma Enters Into Licensing Agreement With c-LEcta 11
c-LEcta GmbH - Key Competitors 12
Key Employees 13
Locations And Subsidiaries 14
Head Office 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List Of Tables
List of Tables
c-LEcta GmbH, Pharmaceuticals & Healthcare, Key Facts 1
c-LEcta GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 1
c-LEcta GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
c-LEcta GmbH, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
c-LEcta GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
c-LEcta GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 8
c-LEcta Enters into Co-Marketing Agreement with Purolite for CalB immo Plus 9
Sartorius Stedim Biotech Enters Into Co-Marketing Agreement With c-LEcta 10
DSM Pharma Enters Into Licensing Agreement With c-LEcta 11
c-LEcta GmbH, Key Competitors 12
c-LEcta GmbH, Key Employees 13

List Of Figures
List of Figures
c-LEcta GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
c-LEcta GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
c-LEcta GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
c-LEcta GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
c-LEcta GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
c-LEcta GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter